Evidence map›Paper›PMID 35003135›Full record

ArticleFrontiers in immunology2021

Longitudinal Variations of

Paulo Ranaivomanana, Rila Ratovoson, Crisca Razafimahatratra, Arimanitra Razafimahefa, Jonathan Hoffmann, Perlinot Herindrainy, Julio Rakotonirina, Niaina Rakotosamimanana

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Tuberculosis in pregnancy.Best practice & research. Clinical obstetrics & gynaecology · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Paulo RanaivomananaMycobacteria Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Rila RatovosonEpidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Crisca RazafimahatratraEpidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Arimanitra RazafimahefaMycobacteria Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Jonathan HoffmannMedical and Scientific Department, Fondation Mérieux, Lyon, France.
Perlinot HerindrainyEpidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Julio RakotonirinaCentre Hospitalier Universitaire de Soins et Santé Publique Analakely (CHUSSPA), Antananarivo, Madagascar.
Niaina RakotosamimananaMycobacteria Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Institut Pasteur de Madagascar · MGFondation Mérieux · FRUniversity of Antananarivo · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pregnancy triggers an alteration of the immune functions and increases the risk of developing the active tuberculosis (TB) symptoms in exposed women. The effect of pregnancy on the Methods: We conducted a prospective cohort study on HIV-seronegative pregnant and non-pregnant women with compatible pulmonary TB symptoms addressed to TB healthcare facilities in Antananarivo, Madagascar. Active pulmonary TB was bacteriologically assessed with culture from sputum samples. Clinical data and blood samples were collected at inclusion and after 6 months of follow-up for each individual included. Whole blood samples were stimulated with QuantiFERON TB-Gold Plus (QFT-P) assay antigens. Plasma IFN-γ concentrations were then assessed by ELISA. Results: A total of 284 women were investigated for the study including 209 pregnant women without confirmed TB (pNTB), 24 pregnant women with bacteriologically confirmed active TB (pATB), 16 non-pregnant women with active TB (ATB), and 35 non-pregnant healthy donors (HC). At inclusion, IFN-γ responses are lower in the pregnant women compared to their age-matched non-pregnant counterparts and independently of their TB status. Among the pregnant women, higher concentrations of Conclusion: These results support the concept of specific immune priorities characterized by a concomitant reduction in inflammatory immunity during pregnancy and corroborate the important role of activating the

Indexed as

AdultCohort StudiesCross-Sectional StudiesFemaleHIV InfectionsHumansInterferon-gammaMadagascarMycobacterium tuberculosisPregnancyPregnancy Complications, InfectiousProspective StudiesTuberculosis, PulmonaryInterferon-gammahuman whole bloodinterferon-gamma release assays (IGRA)pregnancyQuantiFERON-TB Gold Plus®tuberculosis

Identifiers

PMID35003135
PMCPMC8727368
OpenAlexW4200366672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.